Stay updated on SNDX-6352 & Durvalumab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the SNDX-6352 & Durvalumab in Solid Tumors Clinical Trial page.

Latest updates to the SNDX-6352 & Durvalumab in Solid Tumors Clinical Trial page
- Check4 days agoChange DetectedThe page adds new navigation/help items (No longer looking for participants, How to Read a Study Record, Common Questions, How to Join a Study) and updates the Intervention/Treatment heading formatting, while replacing the Revision note from v3.5.5 to v3.6.0.SummaryDifference0.4%

- Check12 days agoChange DetectedRevision updated from v3.5.4 to v3.5.5 on the page, indicating a minor UI/content rendering update.SummaryDifference0.0%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedRevision: v3.5.4 updated from v3.5.3 on the page. This change reflects a backend/content version bump rather than alterations to the study details or public-facing information.SummaryDifference0.0%

- Check47 days agoChange DetectedA new Revision: v3.5.3 tag was added to the page, indicating an update from the previous revision (v3.5.2).SummaryDifference0.0%

- Check62 days agoChange DetectedRevision updated: v3.5.2 added and v3.5.0 removed.SummaryDifference0.0%

- Check83 days agoChange DetectedSite revision indicator updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

Stay in the know with updates to SNDX-6352 & Durvalumab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SNDX-6352 & Durvalumab in Solid Tumors Clinical Trial page.